Cystoid macular degeneration in chronic central serous chorioretinopathy.
about
Characteristics of intraretinal deposits in acute central serous chorioretinopathyOne-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.Hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy.Transpupillary thermotherapy for atypical central serous chorioretinopathy.The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathyFactors influencing the visual acuity of chronic central serous chorioretinopathyOptical coherence tomography characterisation of idiopathic central serous chorioretinopathy.The association between choroidal thickness variations and response to intravitreal bevacizumab in central serous chorioretinopathy.Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy.Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Atypical chronic central serous chorioretinopathy with cystoid macular edema: Therapeutic response to medical and laser therapy.Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.Choroidal ischemia and serous macular detachment associated with severe postoperative pain.Morphologic changes of the fovea and visual acuity associated with retinal detachment secondary to circumscribed choroidal hemangiomaHigh-Resolution Imaging of Intraretinal Structures in Active and Resolved Central Serous Chorioretinopathy.Predicting visual outcomes for macular disease using optical coherence tomography.Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review.Retinal and choroidal changes observed with 'En face' enhanced-depth imaging OCT in central serous chorioretinopathy.Multimodal Imaging in Sympathetic Ophthalmia.Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.Alterations in "in vivo" histology of retina in bilateral chronic central serous chorioretinopathy after intravitreal bevacizumab.Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy.Optical coherence tomography: A guide to interpretation of common macular diseases.Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy.Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy.
P2860
Q26830639-5710981E-7748-44B0-BEB8-0C550E69A58BQ31112014-0DFCFEA1-901D-4828-95DF-16214AD54E0DQ33705962-D1FDB063-B72C-4AC5-9271-5EC03A4258B7Q34036539-5FF69E8D-CDC5-4744-95A7-A269C0460867Q34158234-4B728AFB-68AF-4513-B9AA-65E64D9B7A0DQ34493875-820FA690-64FD-4E60-A3E5-6959D4563AD5Q34695063-CDAB0A10-B96F-4E44-BF58-15EC39D432A6Q35593119-967BDCD6-32CE-4215-AE27-6CDD2F63BA5CQ35657257-DA967153-244F-49AB-97E9-B38DD24FA345Q36127289-4CFFB315-7454-4292-95A3-9C218033ABB0Q36326807-AA8E3739-CD19-43C0-A515-068860EE3081Q36407625-5709C551-A7D3-4518-94A9-EAF100A06F30Q36408674-1086311E-0FD5-47C6-AB9E-5CF0BA5BE774Q36487164-64EF889C-4E1E-46B3-8CD6-FC3C17A9E68FQ36685488-EB400EE5-FF0D-49D2-8105-6E6C42206C6FQ37070185-51EDED1F-B906-4E2A-9012-79C3A0C17EADQ37163436-DD7DE79B-071C-4AD4-B8FE-1E4FEAF8FD9BQ37579624-23086B61-141B-45B4-990B-A649671879E2Q38130239-E22E43F5-B8F5-408E-BDEF-55C01E9A9687Q38160720-8970206F-75FE-43B3-A982-1E61057D902CQ38240884-FA000383-33CE-4FFB-ACEE-CD2F9464807CQ39169021-193D850E-2299-4C24-AE83-1639F9FEAF31Q40411505-AE68CEC9-CC64-4066-A58E-179C3510CC32Q42075080-CA25A413-6EE0-4294-88E2-9793AE1A9580Q42225108-20419F28-1C17-4820-BD21-6E24738F87F4Q47130373-1ECABECF-E942-4196-87F7-5E4D92FADB44Q47570944-30B0110E-2EC9-4321-9145-0D93C532D22DQ49680100-B1CBF8C7-F924-4C45-BEFC-0BA0672DDA70Q50442386-69D546B8-D1F8-4D00-99AB-792AD52F5DF3Q51940763-2C43BBF1-0504-403B-89F6-76AF1539B340Q55400496-2BA6DC59-979F-4B20-9EF3-162F4575E228
P2860
Cystoid macular degeneration in chronic central serous chorioretinopathy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Cystoid macular degeneration in chronic central serous chorioretinopathy.
@en
Cystoid macular degeneration in chronic central serous chorioretinopathy.
@nl
type
label
Cystoid macular degeneration in chronic central serous chorioretinopathy.
@en
Cystoid macular degeneration in chronic central serous chorioretinopathy.
@nl
prefLabel
Cystoid macular degeneration in chronic central serous chorioretinopathy.
@en
Cystoid macular degeneration in chronic central serous chorioretinopathy.
@nl
P2093
P1433
P1476
Cystoid macular degeneration in chronic central serous chorioretinopathy.
@en
P2093
Cynthia A Carvalho
Lawrence A Yannuzzi
Natalie Borodoker
Silvana Negrao
Tomohiro Iida
P304
1-7; quiz 137-8
P356
10.1097/00006982-200302000-00001
P577
2003-02-01T00:00:00Z